Clinical Trials on Accomodation in Canada
Total 1 results
-
SightGlass Vision, Inc.University of WaterlooCompletedMyopia, Myopia Progression, Lag of Accommodation, Hyperopic Retinal Blur, Reduction in ContrastCanada
Sponsors and Collaborators
- The Danish Physiotherapy Foundation
- Metro North Hospital and Health Services
- Shanghai Greenvalley Pharmaceutical Co., Ltd.
- Sana Rouis
- GlaxoSmithKline
- Pei-Yuan Lee, MD
- Zhuzhou Qianjin Pharmaceutical Co., Ltd., 801, Zhuzhou, China
- Collèges Régionaux de Médecine Générale- CRMG - 18600 SANCOINS
- Coalition Internationale Sida
- Società Italiana di Chirurgia Endoscopica e nuove tecnologie (SICE)
- Sidney Kimmel Cancer Center at Thomas Jefferson University
- Acerus Biopharma Inc.
- Hongguan biological pharmaceutical co.
- IGEA
- Atos IT Solutions and Services Iberia
- Dr. Vivek Aggarwal
- Firstbeat Technologies Ltd.
- farzaneh hojjat
- Carol Davila University of Medicine and Pharmacy
- Swim Across America Foundation
- View Full List
Medical Conditions
- Cardiovascular Risk Score
- Colistin Resistance in Bacteria
- Steroids
- Leanness
- Exploring Risk Assessment and Recovery From COVID-19 Infection in Hospitalised Patients
- Stage IVB Mycosis Fungoides and Sezary Syndrome
- CHOP
- Sporadic Angiomyolipomas (AMLs)
- Insulin-like Growth Factor I
- Recurrent Carcinoma of the Vulva
- Femoral Head Collapse
- Care Coordination in Primary Care
- Discetomy
- Landing Error Scoring System (LESS)
- Stage I Skin Melanoma
- Assessment of Skin Moisturization Factors
- Schizoaffective
- Distal Subungual Onychomycosis
- Osteoarthritis in the Hip, Knee and Hand
- Chronic Non Healing Wound
- View Full List
Drug Interventions
- Doxophylline
- AUY922
- B=Inhaled Alprazolam 0.5 mg
- Paclitaxel (albumin-bound) combined with Oxaliplatin and S-1
- [C-11]PiB-PET/MRI
- Insulin (Actrapid)
- TOCOSOL(R) Paclitaxel
- Rose Bengal
- SPARC1104 modified dose regimen III
- R-metHuLeptin
- Medium dose of BIBT 986 CL, per i.v. infusion
- ITF2357
- Citalopram
- Antiretroviral drugs
- 0.9% Sodium Chloride Injection
- BH002
- 5-FU
- Ezabenlimab
- NDI-034858 study drug
- Standard treatment
- View Full List
CROs by country
- Contract Research Organizations in Burundi
- Contract Research Organizations in Estonia
- Contract Research Organizations in Germany
- Contract Research Organizations in India
- Contract Research Organizations in Japan
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Malawi
- Contract Research Organizations in Malta
- Contract Research Organizations in Senegal
- Contract Research Organizations in Tunisia
- Contract Research Organizations in United Arab Emirates
- Contract Research Organizations in United States
- CRO list by country